Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-24T18:18:09.781Z Has data issue: false hasContentIssue false
  • English
  • Français

Moclobemide in social phobia

Published online by Cambridge University Press:  03 January 2018

R. Duffett
R. Duffett*
Affiliation:
The Royal London Hospital (St Clement's) 2A Bow Road, London E3 4LL
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 172 , Issue 5 , May 1998 , pp. 451 - 452
Copyright
Copyright © 1998 The Royal College of Psychiatrists 

References

International Multicenter Clinical Trial Group on Moclobemide in Social Phobia (1997) Moclobemide in social phobia. A double-blind, placebo-controlled clinical study. European Archives of Psychiatry and Clinical Neuroscience, 247, 71–80.Google Scholar
Schneier, F. R., Goetz, D., Campeas, R., et al (1998) Placebo-controlled trial of moclobemide in social phobia. British Journal of Psychiatry, 172, 70–77.CrossRefGoogle ScholarPubMed
Weiller, E., Bisserbe, J. C., Boyer, P., et al (1996) Social phobia in general health care. An unrecognised undertreated disabling disorder. British Journal of Psychiatry, 168, 169–174.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.